diabetestalk.net

Tajao Insulin

Na Dananji Dan - Page 4

Na Dananji Dan - Page 4

- Danas je praznik Prepodobni Aleksije - ovek Boji. U vreme cara Hanorija, u Rimu je iveo visoki carski inovnik Jevtimijan sa enom Aglaidom. I pored velikog bogatstva, iveli su vrlo skromno i odgajili sina jedinca Aleksija. Kad je odrastao, roditelji ga oenie, ali on te iste noi ostavi dom, roditelje i enu i otplovi u grad Edesu u Mesopotamiji, gde je bio uveni lik Isusa Hrista poslan od Gospoda caru Avgaru. Aleksije se pokloni tome liku i presvuen u prosjaka proive 17 godina molei se Bogu. Kada se prou kao bogougodnik, plaei se ljudske slave, krenu laom u Laodikiju, ali udnim sluajem stie u Rim. Smatrajui to Bojom promilju, on osta u Rimu i kao prosjak doe u kuu svoga oca. Milosrdni domain dozvoli prosjaku da ivi u jednoj izbi meu slugama, te Aleksije nastavi svoj podvig ivei na hlebu i vodi sledeih 17 godina. Kada predoseti svoj kraj, napisa neku hartiju i s njom u ruci izdahnu 411. godine. Upravo tada desi se otkrovenje u crkvi svetih apostola u vidu glasa koji ree: "Potraite oveka Boja." Carska i crkvena svita doe u kuu Jevtimijanovu i nae mrtvog Aleksija. Tu roditelji saznae iz one hartije da je to njihov sin, a ena da je to njen mu. Tu je Prepodobni Aleksije i sahranjen, a glava mu se nalazi u Svetoj lavri na Peloponezu. 1746. - Roen je Francisko Goja, panski slikar i graver. Najvie je slikao portrete koji se ubrajaju u najlepe u tom anru. Radio je i kompozicije iz savremenog ivota i istorije, od kojih "Streljanje" obeleava novu epohu u slikarstvu. uveni su mu i nacrti za goblene sa motivima iz ivota panskog drutva. Izradio je i veliki broj gravira na kojima je s neuporedivom invencijom i jezivim sarkazmom prikazao zlodela inkvizicije, strahote rata i ljudske poroke. 1842. - Eter je prvi put kao anestetiko sredstvo upotrebio dr Kroford Long. 1853. - Roen je Vinse Continue reading >>

(insulin Glargine Injection) 300 Units/ml

(insulin Glargine Injection) 300 Units/ml

If you are a patient experiencing problems with a Sanofi US product, please contact Sanofi US at 1-800-633-1610. The health information contained herein is provided for general educational purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment. Continue reading >>

Diabetes Drugs You Inject That Aren't Insulin

Diabetes Drugs You Inject That Aren't Insulin

Insulin isn't the only type of injectable diabetes medicine your doctor might prescribe for you. Other drugs include: Albiglutide (Tanzeum) What it is: It's a man-made version of a hormone called GLP-1 (glucagon-like peptide-1). Your intestines normally release this substance when you eat. It helps control your blood sugar. Who can take it: Adults who have type 2 diabetes and haven’t had success with other treatment. If you're planning to get pregnant, talk with your doctor, since researchers haven't studied albiglutide in pregnant women. What it does: After you eat, albiglutide helps your pancreas release insulin, which moves blood sugar (glucose) into your cells. It also limits how much of the hormone glucagon your body makes. This substance spurs your liver to release stored sugar. The drug also slows down digestion. Side effects: The most common ones are upper respiratory tract infection, diarrhea, nausea, and skin reactions where you give yourself the shot. All GLP-1 drugs, including albiglutide, have a boxed warning noting that in animal studies, this type of drug has been linked to thyroid cancer in some rats and mice. Experts don't know whether it has the same effect in people, though. Inflammation of the pancreas (pancreatitis), which may be severe, is another side effect. Exenatide (Bydureon, Byetta) What it is: Exenatide was the first GLP-1 drug approved by the FDA. Byetta came first. You take it as a shot twice daily. Bydureon is the newer, extended-release version, which you inject once a week. You can't take both drugs. Who can take it: Adults with type 2 diabetes for whom other treatment hasn't worked. If you think you might get pregnant, talk to your doctor. Researchers haven't studied this drug in pregnant women. What it does: Like other GLP-1 drugs, Continue reading >>

Insulin Side Effects

Insulin Side Effects

Applies to insulin: injectable liquid, injectable solution, subcutaneous suspension Endocrine Hypoglycemia is the most common and serious side effect of insulin, occurring in approximately 16% of type 1 and 10% of type II diabetic patients (the incidence varies greatly depending on the populations studied, types of insulin therapy, etc). Although there are counterregulatory endocrinologic responses to hypoglycemia, some responses are decreased, inefficient, or absent in some patients. Severe hypoglycemia usually presents first as confusion, sweating, or tachycardia, and can result in coma, seizures, cardiac arrhythmias, neurological deficits, and death. Blood or urine glucose monitoring is recommended in patients who are at risk of hypoglycemia or who do not recognize the signs and symptoms of hypoglycemia. The risk for developing hypoglycemia is higher in patients receiving intensive or continuous infusion insulin therapy. The association between insulin and dyslipidemia is currently being evaluated.[Ref] Permanent neuropsychological impairment has been associated with recurrent episodes of severe hypoglycemia. In one retrospective study of 600 randomly selected patients with insulin-treated diabetes mellitus, the only reliable predictors of severe hypoglycemia were a history of hypoglycemia, a history of hypoglycemia-related injury or convulsion, and the duration of insulin therapy. Those with a history of hypoglycemia had been treated with insulin for 17.4 years, which was significantly longer than the 14.3 years in the insulin-treated patients without a history of hypoglycemia. Human insulin does not appear to be associated with hypoglycemic episodes more often than animal insulin. Caution is recommended when switching from animal (either bovine or pork) to purified Continue reading >>

Insulin

Insulin

What are Insulin Insulin is a hormone that occurs naturally in the body and can also be given by injection as a treatment for diabetes. Naturally-occurring insulin is made by the beta cells of the Islets of Langerhans located in the pancreas. It helps the cells of the body to uptake glucose (sugar) found in the carbohydrates we eat so that it can be used as energy or stored for later use. Insulin also controls glucose release from the liver. One of the main roles of insulin is to keep blood glucose levels from going too high (hyperglycemia) or too low (hypoglycemia). People with type 1 diabetes do not make enough insulin to satisfy their body's needs or make none at all. Insulin given by injection acts similarly to naturally occurring insulin. There are more than 20 different types of insulin available for diabetes treatment in the United States. The various types of insulin differ in several ways: such as source (animal, human or genetically engineered), the time for insulin to take effect and the length of time the insulin remains working (ie, rapid acting, short acting, intermediate acting, long acting or very long acting). Insulin is used to treat Type 1 diabetes and it may be used together with oral medications in the later stages of Type 2 diabetes. List of Insulin: Filter by: -- all conditions -- Drug Name View by: Brand | Generic Reviews Avg. Ratings Humulin R (Pro, More...) generic name: insulin regular 0 reviews 10 NovoLog Mix 70 / 30 FlexPen (More...) generic name: insulin aspart/insulin aspart protamine 0 reviews 10 Humalog Mix 75 / 25 (More...) generic name: insulin lispro/insulin lispro protamine 2 reviews 9.5 NovoLog Mix 70 / 30 (More...) generic name: insulin aspart/insulin aspart protamine 3 reviews 9.5 ReliOn / Novolin 70 / 30 (More...) generic name: i Continue reading >>

Should My Insulin Dose Be Lower? Toujeo Vs Lantus

Should My Insulin Dose Be Lower? Toujeo Vs Lantus

Early in 2015 the FDA approved the first concentrated long-acting insulin known as Toujeo (insulin glargine), and it’s now available in pharmacies. While Toujeo is the first of its kind, the key word is “concentrated.” It actually contains the same active ingredient (insulin glargine) as Lantus—which is currently the #1 prescribed insulin in the US. To make things even more confusing: Toujeo comes in a 300 mg/mL dosage, while Lantus is 100 mg/mL. Knowing that Toujeo is concentrated, you might think that you can take a much smaller amount of Toujeo for a similar dose compared to Lantus. Believe it or not though, that isn’t the case. Lantus and Toujeo doses are converted 1:1. This means that if you are injecting 50 units of Lantus, you can essentially be switched over to Toujeo and instructed to inject the exact same amount, 50 units. In reality, some dose adjustments can be expected (according to clinical trial data), but it isn’t a matter of converting to a three times smaller dose. Surprisingly, patients who switch over to Toujeo are actually injecting higher doses compared to what they were using for Lantus. I see a lot of confusion around the different dosages, and a few common questions: Is it normal for my dose of Toujeo to be more than my Lantus dose? Yes. Although Toujeo has three times the concentration of insulin glargine, patients treated with Toujeo during clinical trials used more insulin than patients treated with Lantus in order to maintain the same level of blood sugar control. According to the manufacturer, Sanofi-Aventis, a higher dose can be expected with Toujeo and is completely normal. Why would Sanofi-Aventis make Toujeo if Lantus is the most-prescribed insulin? There is speculation that Sanofi-Aventis came up with Toujeo due to the upco Continue reading >>

Fda Approves New Long-acting Insulin

Fda Approves New Long-acting Insulin

On February 25, 2015, the U.S. Food and Drug Administration (FDA) approved the once-daily, long-acting insulin Toujeo (generic name insulin glargine 300 U/ml) for controlling blood glucose in adults with Type 1 and Type 2 diabetes. The medicine, which is manufactured by pharmaceutical company Sanofi, joins basal insulins Lantus (insulin glargine 100 U/ml) and Levemir (insulin detemir) on the U.S. market. Basal, or background insulin, is typically taken once daily to cover the liver’s secretion of glucose into the bloodstream. Toujeo has the same active ingredient as Lantus, but it is three times the concentration and is designed to release more gradually. In a series of international studies involving more than 3,500 adults with Type 1 and Type 2 diabetes, Toujeo produced similar blood glucose control to Lantus, but with lower rates of hypoglycemia (low blood glucose). This medicine should not be used in people under 18 or to treat diabetic ketoacidosis (a potentially life-threatening condition marked by a chemical imbalance in the body). The most common side effects of Toujeo (apart from hypoglycemia) are nasopharyngitis (inflammation of the nose and pharynx) and upper respiratory tract infection. Toujeo is expected to debut in the United States in April 2015 and will be available in the Toujeo SoloSTAR, a prefilled, disposable pen containing 450 units of the medicine. Information on pricing is not currently available. For more information about Toujeo, see the press release on Sanofi’s website or visit the official Toujeo website. And to learn more about using long-acting insulin, see “Getting Down to Basals,” by 2014 Diabetes Educator of the Year Gary Scheiner. Continue reading >>

Dogodilo Se Na Danasnji Dan

Dogodilo Se Na Danasnji Dan

1736. - U Budimu je muenjem na toku umoren voa srpskih ustanika Pera Segedinac, koji je 1735. u Pomoriju, Bakoj i Posavini podigao Srbe protiv Bea. Da bi zastraile buntovne Srbe, austrijske vlasti su mrtvog Segedinca odnele u Peku i obesile. Srbi su se digli na bunu zbog mobilizacije u austrijsku vojsku, a ustanak se proirio meu seljacima. Moriki komandant i oberstvahtmajster opevan je u narodnim pesmama, a srpski pisac Laza Kosti napisao je dramu "Pera Segedinac". 1837. - Kanada je dala pravo glasa crncima. 1941. - Jugoslovenski premijer Dragia Cvetkovi i ef diplomatije Aleksandar Cincar-Markovi tajno su otputovali u Be da bi 25. marta potpisali ugovor o pristupanju Jugoslavije Trojnom paktu. Vlada je oborena vojnim udarom tri dana kasnije, posle masovnih demonstracija u Beogradu i drugim gradovima u Srbiji. 1945. - U Beogradu je potpisan sporazum vlade Demokratske Federativne Jugoslavije i Uprave UN za pomo i obnovu. Sporazumom je predvieno da UNRA pomogne u hrani, lekovima, obui i odei i da uputi strunjake za obnovu poljoprivrede, industrije i saobraaja. 1949. - Volter i Don Hjuston postali su prvi "otac - sin" tim koji je osvojio Oskare - glumac i reiser. 1958. - Elvis Prisli pristupio je vojsci. Njegov serijski broj bio je 53310761. 1990. - Indijske trupe napustile su ri Lanku. 1996. - enon Lucid, ameriki astronaut, postala je prva ena koja je ivela u svemirskoj stanici. 1999. - NATO je otpoeo agresiju na Saveznu Republiku Jugoslaviju, pod izgovorom "spreavanja humanitarne katastrofe" iptara na Kosovu i Metohiji. Agresijom na suverenu zemlju NATO je pogazio Povelju UN, ali i sopstveni osnivaki akt kojim je pola veka ranije definisan kao odbrambeni savez. To je uinio mimo saglasnosti Saveta bezbednosti UN, suprotno dokumentu o evropskoj bezbednosti iz Helsinkija ko Continue reading >>

Toujeo Insulin: The Major Problem I Had With This Insulin

Toujeo Insulin: The Major Problem I Had With This Insulin

I was in love with Toujeo insulin when I first started taking it. It addressed my two major complaints with Lantus insulin: the 5-hour peak after injecting it (which means my blood sugar would plummet between 3 a.m. and 5 a.m. down to 40 mg/dL) and the burning pain it caused in every injection because its very acidic. These are two things I can certainly work around, by going to bed with my blood sugar 130 mg/dL instead of 80 mg/dL (not ideal!) and by just dealing with the 10 seconds on burning pain…but what would be even better is an insulin that didn’t burn and didn’t peak 5 hours after injecting it. At first, it seemed like Toujeo was going to be that solution. I started taking it near the end of September. I was so in love with this insulin that I wrote this article, Toujeo: 5 Reasons Why I Love It! I can’t recall exactly when things started to go haywire, but it was after at least two or three weeks of taking Toujeo. The first few weeks were wonderful. Smooth and steady blood sugars. No burning pain. No lows at 5 a.m. Wonderful. The recommended conversion of your Lantus dose to your Toujeo dose seemed to be perfect for me: a 20% increase in your Lantus dose should be your Toujeo dose, because even though Toujeo is more concentrated (a u300 insulin), you actually need more, not less. Then Things Got Messy… And then things got messy. And gradually, over the course of two months, they continued to get even messier. Unfortunately, I wasn’t able to wear my DexCom CGM during this span of time because my receiver died in early November and I’ve been going through the painfully slow process of getting my new one because of insurance nonsense. Regardless, it would’ve been extremely helpful to have my CGM on during this span of time! It’s Gotta Be My Fault Continue reading >>

Fda Approves Sanofi's Diabetes Drug Toujeo

Fda Approves Sanofi's Diabetes Drug Toujeo

February 26, 2015 / 1:55 AM / 3 years ago FDA approves Sanofi's diabetes drug Toujeo (Reuters) - U.S. health regulators on Wednesday approved Sanofis diabetes drug Toujeo, a more potent follow-up to the French drugmakers top-selling insulin product Lantus. The Food and Drug Administration approved the once daily, long-acting basal insulin to treat adults with both type 1 and the far more prevalent type 2 diabetes. The medicine is considered among the most important in Sanofis pipeline. The company is expected to try to convert patients from Lantus to Toujeo as quickly as possible, with the older drug about to lose U.S. patent protection. Sanofi bought some time with a patent infringement lawsuit filed last year against Eli Lilly and Co that would keep a cheaper Lantus generic off the market for 30 months. In addition gaining Toujeo patients through conversions, theres about a million new patients for basal insulin each and every year, said Joe Balzer, head of U.S. commercial operations for Toujeo, which is awaiting a European approval decision. Toujeo has the same active ingredient as Lantus, called insulin glargine, but at three times the concentration and with a design to release the insulin more gradually. The medicine provides similar blood glucose control as Lantus with significantly lower rates of hypoglycemia, a potentially dangerous drop in blood sugar. Lantus, the worlds most prescribed insulin with sales of $7.2 billion in 2014, accounts for more than 30 percent of Sanofi profit. Warnings of faltering U.S. Lantus sales contributed to the sudden sacking of Sanofi Chief Executive Officer Chris Viehbacher last year. His successor, Olivier Brandicourt, is set to assume the top post on April 2, about the same time Sanofi plans to begin selling Toujeo. The company Continue reading >>

Understanding The Two Types Of Diabetes

Understanding The Two Types Of Diabetes

The number of diabetes cases in the world is growing out of control. There are two kinds of diabetes: Type 1 diabetes This type of diabetes is an autoimmune disease where insulin production shuts down. It is irreversible, and people who have it require insulin shots to survive. This condition is also referred to as insulin-dependent diabetes. Type 2 diabetes Unlike the other form, type 2 diabetes is directly influenced by diet and lifestyle. More specifically, it is caused by the loss of insulin and leptin sensitivity. Unlike type 1 diabetes, it is completely preventable and almost 100 percent reversible. Only five to 10 percent of people who have diabetes have type 1 diabetes. Type 1 diabetes occurs when the immune system attacks the pancreatic cells that produce insulin. Patients then develop insulin deficiency. Because of this, diagnosis needs to be done as soon as possible, or else it can be life-threatening. Complications that may arise from type 1 diabetes are blindness, kidney problems, heart problems, and stroke. Although the number of type 1 diabetes patients is smaller than those who suffer from type 2 diabetes, the numbers are increasing. Type 1 is often found in people under age 20. According to a study published in the Lancet, it is expected that the cases of type 1 diabetes in children under five will double until the year 2020, whereas a 70 percent rise in cases in children under 15 will occur during the projected time. At this point in time, prevention is the only option for this form of diabetes. Studies have confirmed that sun avoidance is linked to the development of this form of diabetes. Those who live in regions without much sunlight exposure are found to have a higher risk of developing type 1 diabetes. Mothers can reduce their childrens risk of Continue reading >>

More in insulin